TR201821115A2 - Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m - Google Patents

Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m Download PDF

Info

Publication number
TR201821115A2
TR201821115A2 TR2018/21115A TR201821115A TR201821115A2 TR 201821115 A2 TR201821115 A2 TR 201821115A2 TR 2018/21115 A TR2018/21115 A TR 2018/21115A TR 201821115 A TR201821115 A TR 201821115A TR 201821115 A2 TR201821115 A2 TR 201821115A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
levosetirizin
composition containing
containing montelukast
montelukast
Prior art date
Application number
TR2018/21115A
Other languages
English (en)
Inventor
Aktaş Tolga
Buğra Doğru Meli̇k
Original Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201821115A2 publication Critical patent/TR201821115A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, montelukast, levosetirizin veya bunların farmasötik olarak kabul edilebilir bir tuzunu, 5 esterini, hidratını, solvatını veya türevini, en az bir tane şeker alkolü ve en az bir tane farmasötik olarak kabul edilebilir yardımcı maddeyi içeren katı oral dozaj formunda farmasötik bileşim ve bu bileşimin üretim yöntemi ile ilgilidir
TR2018/21115A 2017-12-31 2018-12-30 Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m TR201821115A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17020597.5A EP3505172A1 (en) 2017-12-31 2017-12-31 A pharmaceutical composition comprising montelukast and levocetirizine

Publications (1)

Publication Number Publication Date
TR201821115A2 true TR201821115A2 (tr) 2019-07-22

Family

ID=61258112

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/21115A TR201821115A2 (tr) 2017-12-31 2018-12-30 Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m

Country Status (2)

Country Link
EP (1) EP3505172A1 (tr)
TR (1) TR201821115A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114053231A (zh) * 2020-07-29 2022-02-18 北京兴源祥生物科技有限公司 一种有色的孟鲁司特钠冻干口腔崩解片

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
US20070086974A1 (en) * 2005-10-06 2007-04-19 Gawande Rahul S Cetirizine compositions
WO2010107404A1 (en) 2009-03-16 2010-09-23 Mahmut Bilgic Stable pharmaceutical combinations
CN104546851B (zh) * 2013-10-29 2018-01-02 北京韩美药品有限公司 一种颗粒组合物及其制备方法、制剂

Also Published As

Publication number Publication date
EP3505172A1 (en) 2019-07-03

Similar Documents

Publication Publication Date Title
NZ742220A (en) Pharmaceutical compositions comprising meloxicam
BR112016001678A2 (pt) Composição, método de fabricação de um comprimido, comprimido, forma de dosagem unitária, artigo de fabricação, e, uso de uma composição, de um comprimido ou de uma forma de dosagem unitária
GT201600142A (es) Composiciones farmacéuticas que comprenden azd9291
EA201992116A1 (ru) Фармацевтические составы флороглюцинола и триметилфлороглюцинола
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
EA201792591A1 (ru) Фармацевтические препараты
MX2016002580A (es) Combinacion de un inhibidor de alk y un inhibidor de cdk para el tratamiento de enfermedades celulares proliferativas.
MX2019012757A (es) Composicion farmaceutica para administracion oral que comprende enzalutamida.
BR112017013253A2 (pt) comprimidos de desintegração oral, processo para produzir comprimido de desintegração oral contendo tofacitinibe ou seus sais farmaceuticamente aceitáveis, processo para produzir comprimido de desintegração oral, desintegrante, e edulcorantes
IL282163A (en) A pharmaceutical preparation for oral administration containing an aminopyrimidine derivative or its salt
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos
BR112015020019A2 (pt) pastilha para tratamento de dor de garganta, rouquidão e tosse seca associada e de doenças inflamatórias da cavidade oral e faríngea
TR201821115A2 (tr) Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
EP3888647A4 (en) EZH1/2 DUAL INHIBITOR CONTAINING PHARMACEUTICAL COMPOSITION FOR USE AS COMBINATION MEDICINAL PRODUCT
TR201821114A2 (tr) Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m
WO2016165205A8 (zh) 一种新型的bcr-abl激酶抑制剂
TR201310724A2 (tr) Linagliptinin farmasotik formulasyonları.
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
MX370184B (es) Composición farmacéutica que comprende fingolimod.
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
CY1119701T1 (el) Σταθερη φαρμακευτικη συνθεση που περιεχει υδροχλωρικη βαρδεναφιλη
TR201818990A2 (tr) Sefdi̇ni̇r i̇çeren tablet formülasyonu
BR112016029417A8 (pt) composição farmacêutica que compreende desmopressina, uso de uma ou mais gomas para aumentar sua estabilidade, película de desintegração oral e seu método de preparação
TR201722102A2 (tr) Levodropropizin İçeren Farmasötik Bir Ürün